TCL Archive In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief January 6, 1995
TCL Archive On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases October 1, 1999
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
